文献速递甲状腺与浅表头颈技术与安全US

实体甲状腺结节超微血管成像(SMI)微血流模式诊断效能评估及影响因素:什么因素重要?

Efficacy Assessment and Influencing Factors on Superb Microvascular Imaging (SMI) Microflow Patterns in Solid Thyroid Nodules: What Matters?
PubMed 文献 · Ultrasound Med Biol · 2025-06-14

回顾性分析2020年1月至2023年7月560例患者783个病理确诊甲状腺结节,评估SMI血流分型(I-VIb型)鉴别良恶性的效能。SMI敏感度89.5%、特异度85.4%、AUC 0.896;结节深度≤7.5 mm者诊断效能优于>7.5 mm者,肿瘤大小和BMI与SMI效能无关。

要点

  • SMI血流分型VIb型与恶性风险相关性最强(OR 220.39)。
  • 结节深度≤7.5 mm者SMI诊断效能优于>7.5 mm者。
  • 肿瘤大小和患者BMI与SMI诊断效能无相关性。

核心结论

  • SMI对甲状腺病变诊断效能高,是颇有前景的诊断工具。
  • 结节深度是影响SMI诊断效能的关键因素。
  • 研究结果可能有助于改善甲状腺结节的临床风险评估和管理策略。

研究设计与样本

  • 回顾性分析,纳入2020年1月至2023年7月560例患者共783个病理确诊的甲状腺结节。
  • 记录患者年龄、性别、BMI,常规超声评估并按ACR TI-RADS分类,测量结节大小和深度。
  • 行SMI评估血管模式并分为六型(I-VIb型),以组织病理学结果为参考标准计算诊断效能。

关键影像表现/征象

  • SMI血管分布良恶性结节间差异有统计学意义(p < 0.001)。
  • SMI血管分型越高,恶性风险越高:III型OR 8.55、IV型OR 6.77、V型OR 9.20、VIa型OR 89.71、VIb型OR 220.39。

诊断标准与关键数值

  • SMI诊断敏感度89.5%、特异度85.4%、准确率87.7%、PPV 89.1%、NPV 85.9%、AUC 0.896(95% CI: 0.876-0.920)。
  • 结节深度≤7.5 mm者诊断效能优于>7.5 mm者(DeLong检验 Z = 3.11, p = 0.0019)。
  • 多因素logistic回归:年龄增大(OR: 0.92, 95% CI: 0.90-0.95, p < 0.001)和女性(OR: 0.36, 95% CI: 0.18-0.70, p = 0.003)与恶性几率降低相关。
  • ACR TI-RADS TR5是恶性独立预测因子(OR: 49.94, 95% CI: 16.49-151.20, p < 0.001)。

临床应用与阅片要点

  • 阅片时采用SMI六型分类(I-VIb型)评估血流模式,高型别提示恶性风险增加。
  • 评估SMI时需考虑结节深度,深度>7.5 mm者SMI诊断效能可能受影响。
  • SMI诊断效能与肿瘤大小和患者BMI无相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aims to evaluate the diagnostic efficacy of Superficial Microvascular Imaging (SMI) in differentiating benign from malignant thyroid nodules and to identify influencing factors such as patient body mass index (BMI), tumor size, and nodule depth.

METHODS: A retrospective analysis was conducted involving 560 patients with 783 pathologically confirmed thyroid nodules between January 2020 and July 2023. Patient demographics, including age, sex, and BMI, were recorded. Thyroid nodules were evaluated using conventional ultrasonography and classified by ACR TI-RADS. Nodule size and depth were measured. Subsequently, Superb Microvascular Imaging (SMI) was performed to assess vascular patterns, classified into six types (I-VIb). Diagnostic performance metrics, including sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) were calculated based on histopathological results. Logistic regression analyses identified independent predictors of malignancy, while the impact of BMI, tumor size, and nodule depth on SMI performance was analyzed.

RESULTS: Among the 783 thyroid nodules analyzed, 335 were benign and 448 were malignant. Statistically significant differences were observed between benign and malignant nodules in terms of patient age (p < 0.001), sex (p = 0.032), nodule size (p = 0.025), ACR TI-RADS level (p < 0.001), and vascular distribution on SMI (p < 0.001). Multivariate logistic regression analysis identified several independent predictors of malignancy in thyroid nodules. Increasing age (OR: 0.92, 95% CI: 0.90-0.95, p < 0.001) and female sex (OR: 0.36, 95% CI: 0.18-0.70, p = 0.003) were associated with significantly lower odds of malignancy. Among ACR TI-RADS levels, TR5 emerged as a robust independent predictor of malignancy (OR: 49.94, 95% CI: 16.49-151.20, p < 0.001). Regarding SMI vascular distribution, higher vascular types were strongly associated with an increased risk of malignancy. Specifically, Type III (OR: 8.55, 95% CI: 1.82-40.14, p = 0.007), Type IV (OR: 6.77, 95% CI: 2.68-17.12, p < 0.001), Type V (OR: 9.20, 95% CI: 3.69-22.91, p < 0.001), Type VIa (OR: 89.71, 95% CI: 20.36-395.25, p < 0.001), and Type VIb (OR: 220.39, 95% CI: 42.07-1154.47, p < 0.001) demonstrated a stepwise increase in odds ratios, with Type VIb showing the strongest correlation. The diagnostic performance of SMI was high, achieving a sensitivity of 89.5%, specificity of 85.4%, overall accuracy of 87.7%, positive predictive value (PPV) of 89.1%, negative predictive value (NPV) of 85.9%, and an area under the curve (AUC) of 0.896 (95% CI: 0.876-0.920). Notably, nodule depth significantly influenced diagnostic accuracy. Nodules with depths ≤7.5 mm demonstrated superior diagnostic performance compared to those >7.5 mm (DeLong's test; Z = 3.11, p = 0.0019), while tumor size and patient BMI did not correlate with SMI efficacy.

CONCLUSION: SMI is a promising diagnostic tool for thyroid lesions, demonstrating high diagnostic efficacy. The study highlights the significance of nodule depth as a critical factor influencing SMI's performance. These findings may enhance clinical risk assessment and management strategies for thyroid nodules, ultimately leading to improved patient outcomes.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Luo Z, Sun Y, Pan H, et al. Efficacy Assessment and Influencing Factors on Superb Microvascular Imaging (SMI) Microflow Patterns in Solid Thyroid Nodules: What Matters? Ultrasound Med Biol. 2025. PMID: 40518320. doi:10.1016/j.ultrasmedbio.2025.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。